Standard radiotherapy but not chemotherapy impairs systemic immunity in non-small cell lung cancer

Introduction: Advanced non-small cell lung cancer (NSCLC) is traditionally treated with platinum-based chemotherapy and radiotherapy. Since immunotherapy holds promise for treating advanced NSCLC, we assessed the systemic effects of the traditional therapies for NSCLC on immune cell composition and...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncoimmunology
Egile Nagusiak: Talebian Yazdi, Mehrdad, Schinkelshoek, Mink S., Loof, Nikki M., Taube, Christian, Hiemstra, Pieter S., Welters, Marij J. P., van der Burg, Sjoerd H.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis 2016
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5214754/
https://ncbi.nlm.nih.gov/pubmed/28123900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1255393
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak